2019 Analytical Report for Healthcare Licensing with Focus on Personalized Medicine - ResearchAndMarkets.com

DUBLIN--()--The "Analytical Report for Healthcare Licensing with Focus on Personalized Medicine" report has been added to ResearchAndMarkets.com's offering.

Better diagnoses, earlier interventions, more-efficient drug therapies, customized treatment plans. These are the promises of personalized medicine. The licensing scenario for personalized medicine is useful to be familiar with and thus is studied in this report. 100+ licensing news with a focus on Personalized Medicine, during January 1, 2018, to August 31, 2019, are reported and analyzed to provide a snapshot view of the current business trends.

Analytical data coverage:

  • January 1, 2018, to August 15, 2019, licensing deals and negotiations
  • 100+ worldwide Personalized Medicine focused healthcare licensing news of companies across North America (63%), Europe (25%), Asia (10%)
  • Small-mid-large cap companies covered - LargeCap (18%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered - Pharmaceuticals (23%), Biotech (27%), Healthcare Services (24%), Medical Devices (22%)
  • 14 medicine groups studied - Oncology (33%), Neurology (10%)
  • 8+ variables analyzed

User benefits:

  • Immediate access to current global licensing trends for Personalized Medicine
  • Succinct summaries of licensing deals and negotiations held worldwide
  • Quick to-the-point analytical references
  • In-depth updates on the wider perspective of Personalized Medicine
  • Directions to the emerging business prospects

Key analysis in the report:

  • Leading countries in Personalized Medicine focused licensing
  • Most active healthcare sub-sectors in Personalized Medicine focused licensing
  • Distribution of Personalized Medicine focused licensing deals among market cap groups
  • Comparisons of different medicine groups in Personalized Medicine focused licensing
  • Companies currently engaging the most in Personalized Medicine focused licensing
  • Dynamics of varied licensing payments arrangements worldwide

Report useful to:

  • Personalized Medicine focused healthcare companies seeking licensing opportunities
  • Personalized Medicine focused healthcare companies seeking a new market base
  • Executives of healthcare companies negotiating to license for Personalized Medicine
  • Investors analyzing varied kinds of transaction options for Personalized Medicine focused licensing

Key Topics Covered:

Introduction

Research Design

Chapter 1: Analysis of healthcare inventions with focus on Personalized Medicine licensed during the past 20 months

1.1 Number of licensing deals with focus on Personalized Medicine

1.2 Countries with most licensing deals with focus on Personalized Medicine

1.3 Healthcare sub-sectors with most licensing deals with focus on Personalized Medicine

1.4 Market capitalization groups with most licensing deals with focus on Personalized Medicine

1.5 Medicine groups with most licensing deals with focus on Personalized Medicine

1.6 Leading companies with most licensing deals with focus on Personalized Medicine

1.7 Licensing payment arrangements most followed in licensing deals with focus on Personalized Medicine

Chapter 2: Key licensing deals with focus on Personalized Medicine during the past 20 months - By type of licensing deal

Chapter 3: Global healthcare inventions with focus on Personalized Medicine licensed during the past 20 months - By region and company name

Chapter 4: Summary and conclusions

Appendices

Appendix 1 List of companies/institutes covered

a) By region, country and company name

b) By sub-industry, country and company name

c) By market capitalization group, country and company name

d) By medicine group, country and company name

e) By terms of payment, country and company name

Appendix 2 List of non-listed companies covered - By country and company name

Appendix 3 List of not-for-profit institutes covered - By country and institute name

For more information about this report visit https://www.researchandmarkets.com/r/zneee

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900